SEC Form 5 · accession 0001570523-18-000015
Immune Therapeutics, Inc. · IMUN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
Dec 31, 2017
Accepted (ET)
Mar 30, 2018 · 3:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001559356
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | May 4, 2016 | P | 500 | $0.1499 | A | 20,800,359 | D | |
| Common stock | May 5, 2016 | P | 1,000 | $0.1549 | A | 20,800,359 | D | |
| Common stock | May 6, 2016 | P | 1,250 | $0.159 | A | 20,800,359 | D | |
| Common stock | May 6, 2016 | P | 750 | $0.16 | A | 20,800,359 | D | |
| Common stock | May 10, 2016 | P | 13,940 | $0.149 | A | 20,800,359 | D | |
| Common stock | May 10, 2016 | P | 6,060 | $0.1489 | A | 20,800,359 | D | |
| Common stock | May 10, 2016 | P | 10,000 | $0.1489 | A | 20,800,359 | D | |
| Common stock | May 10, 2016 | P | 500 | $0.1489 | A | 20,800,359 | D | |
| Common stock | May 10, 2016 | P | 500 | $0.149 | A | 20,800,359 | D | |
| Common stock | May 11, 2016 | P | 1,000 | $0.1447 | A | 20,800,359 | D | |
| Common stock | May 11, 2016 | P | 9,000 | $0.14 | A | 20,800,359 | D | |
| Common stock | May 11, 2016 | P | 1,000 | $0.1399 | A | 20,800,359 | D | |
| Common stock | May 11, 2016 | P | 10,000 | $0.1167 | A | 20,800,359 | D | |
| Common stock | May 11, 2016 | P | 10,000 | $0.1179 | A | 20,800,359 | D | |
| Common stock | May 12, 2016 | P | 1,000 | $0.1448 | A | 20,800,359 | D | |
| Common stock | May 12, 2016 | P | 1,000 | $0.1399 | A | 20,800,359 | D | |
| Common stock | May 12, 2016 | P | 1,000 | $0.1408 | A | 20,800,359 | D | |
| Common stock | May 12, 2016 | P | 1,000 | $0.139 | A | 20,800,359 | D | |
| Common stock | May 13, 2016 | P | 1,000 | $0.1399 | A | 20,800,359 | D | |
| Common stock | May 13, 2016 | P | 1,000 | $0.1399 | A | 20,800,359 | D | |
| Common stock | May 16, 2016 | P | 1,000 | $0.147 | A | 20,800,359 | D | |
| Common stock | May 16, 2016 | P | 1,000 | $0.1466 | A | 20,800,359 | D | |
| Common stock | May 19, 2016 | P | 6,000 | $0.13 | A | 20,800,359 | D | |
| Common stock | May 19, 2016 | P | 1,000 | $0.1296 | A | 20,800,359 | D | |
| Common stock | Jun 9, 2016 | P | 2,000 | $0.1439 | A | 20,800,359 | D | |
| Common stock | Jun 13, 2016 | P | 5,000 | $0.151 | A | 20,800,359 | D | |
| Common stock | Jun 13, 2016 | P | 3,000 | $0.155 | A | 20,800,359 | D | |
| Common stock | Jun 13, 2016 | P | 2,000 | $0.1609 | A | 20,800,359 | D | |
| Common stock | Jun 13, 2016 | P | 6,000 | $0.1649 | A | 20,800,359 | D | |
| Common stock | Jun 13, 2016 | P | 1,000 | $0.1649 | A | 20,800,359 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
This is part 11 of 16 submissions.